Altamira Therapeutics Ltd. Adjustments For Fair Value Gains Losses
Altamira Therapeutics Ltd. (CYTOF) reported Adjustments For Fair Value Gains Losses of -$14.92 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Income Statement › Other Income
ifrs-full:AdjustmentsForFairValueGainsLosses · last filed 2025-08-29
CHF
| Period end | Adjustments For Fair Value Gains Losses 6 month | Adjustments For Fair Value Gains Losses 12 month |
|---|---|---|
| 2023-12-31 | -29.46K CHF 20-F/A · filed 2024-04-22 | |
| 2023-06-30 | -29.46K CHF 6-K · filed 2023-09-12 |
USD
| Period end | Adjustments For Fair Value Gains Losses | Adjustments For Fair Value Gains Losses 6 month | Adjustments For Fair Value Gains Losses 12 month |
|---|---|---|---|
| 2025-06-30 | -$14.92K 6-K · filed 2025-08-29 | ||
| 2025-05-19 | -$14.92K 6-K · filed 2025-08-29 | ||
| 2023-12-31 | -$32.79K 20-F · filed 2025-04-30 | ||
| 2023-06-30 | -$32.31K 6-K · filed 2024-09-24 |